Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Vladimir Putin
United Nations (UN)
United States of America
COVID-19
China
Pakistan
Russia-Ukraine crisis
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
World

Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week

Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
Written by Ramya Patelkhana
Aug 21, 2021, 11:27 am 3 min read
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
Credits:
US: FDA likely to give full approval to Pfizer-BioNTech vaccine against COVID-19 next week

The United States Food and Drug Administration (FDA) is reportedly set to grant full approval to Pfizer-BioNTech's two-dose COVID-19 vaccine next week, expediting the previous timeline for licensing the vaccine. To note, the vaccine was approved in the US on an emergency use authorization (EUA) license back in December. The company began the process of applying for full approval in May. Here's more.

Details
Full approval likely to persuade more Americans to get vaccinated

Reports of the Pfizer-BioNTech vaccine receiving full approval come at a time President Joe Biden's administration is intensifying efforts to get more Americans to receive COVID-19 vaccines. FDA's full approval is expected to persuade more people to take the shot as many were hesitant to receive vaccines approved on EUA basis. Meanwhile, health authorities believe it would help local authorities implement vaccine mandates easily.

Vaccinations
Move is expected to prompt vaccinations among holdouts

While the current vaccines in the US—approved for emergency use—are safe and effective, the Biden administration hopes full approval applying to those aged 16 and above will prompt vaccinations among holdouts waiting for FDA to formally approve the Pfizer shot. A Kaiser Family Foundation survey found 30% of unvaccinated people are more likely to get a fully-approved vaccine than something cleared for emergency use.

Booster dose
Pfizer to ask FDA to approve third dose as booster

After receiving full approval, Pfizer-BioNTech is reportedly planning to request FDA to clear the third dose of its vaccine as a booster shot. Next week, Pfizer would complete submitting data, showing a third dose is safe and effective. Even the Biden administration, earlier on Wednesday, said fully-vaccinated adults should prepare to receive booster shots eight months after taking their second doses, starting September 20.

Approval process delayed
Drug regulators were working on finishing approval process by Friday

Bloomberg reported the Pfizer-BioNTech's COVID-19 vaccine—sold under the Comirnaty brand name—would get full approval from the FDA Monday or Tuesday, citing an official familiar with the development. American drug regulators were working on finishing the approval process for the shot by Friday but it was delayed due to a large amount of paperwork and negotiations with the pharma giant, according to New York Times.

About
Pfizer-BioTech vaccine has been developed on a nucleoside-modified mRNA platform

The Pfizer-BioTech vaccine has been developed on a nucleoside-modified mRNA platform to deliver a mutated form of SARS-CoV-2's spike protein through lipid nanoparticles. It was developed by American pharmaceutical company, Pfizer, and German biotechnology company, BioNTech. Initially, the gap between its two doses was 21 days, but it was later increased to up to 42 days in the US and four months in Canada.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Ramya Patelkhana
Ramya Patelkhana
Mail
Ramya Patelkhana is a senior editor at NewsBytes. She has nearly seven years of experience in digital journalism and has previously worked with India News and Authint Media. She has a Bachelor's degree in Journalism and Mass Communication from the IK Gujral Punjab Technical University, Kapurthala, and an advanced diploma in Media Studies from IPW, New Delhi.
Latest
Pfizer
Joe Biden
Food and Drug Administration
Coronavirus
COVID-19
Related
Latest
Apple stops accepting credit or debit cards for subscriptions, purchases
Apple stops accepting credit or debit cards for subscriptions, purchases Business
5 couples we want on 'Koffee with Karan' S07 couch
5 couples we want on 'Koffee with Karan' S07 couch Entertainment
Ferrari SP48 Unica debuts as a V8-powered one-off supercar
Ferrari SP48 Unica debuts as a V8-powered one-off supercar Auto
5 films you can watch on OTT this weekend
5 films you can watch on OTT this weekend Entertainment
Royal Enfield Classic 350 becomes costlier: Check new prices
Royal Enfield Classic 350 becomes costlier: Check new prices Auto
Pfizer
New Omicron sub-variants can trigger new COVID-19 wave: Study
New Omicron sub-variants can trigger new COVID-19 wave: Study World
Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine
Pfizer, BioNTech begin clinical trial for Omicron-specific vaccine World
'Cautious optimism' after initial Omicron studies; here's what we know
'Cautious optimism' after initial Omicron studies; here's what we know Technology
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Technology
COVID-19: India reports 10K+ infections; 301 more deaths
COVID-19: India reports 10K+ infections; 301 more deaths India
More News
Joe Biden
US: Supreme Court to repeal abortion law, leaked draft shows
US: Supreme Court to repeal abortion law, leaked draft shows World
Russia-Ukraine war: 'Battle for Donbas' has begun, says President Zelenskyy
Russia-Ukraine war: 'Battle for Donbas' has begun, says President Zelenskyy World
Russia-Ukraine war: 'Missile strikes on Kyiv will increase,' says Russia
Russia-Ukraine war: 'Missile strikes on Kyiv will increase,' says Russia World
New York shooting: Manhunt on for 62-year-old 'person of interest'
New York shooting: Manhunt on for 62-year-old 'person of interest' World
Modi to hold virtual meeting with Biden today: Details here
Modi to hold virtual meeting with Biden today: Details here India
More News
Food and Drug Administration
Pfizer pill cuts risk of severe COVID-19 by 89%
Pfizer pill cuts risk of severe COVID-19 by 89% World
Onion-linked salmonella: US FDA launches probe as hundreds fall ill
Onion-linked salmonella: US FDA launches probe as hundreds fall ill World
US allows entry to fully vaccinated adults. Can Indians travel?
US allows entry to fully vaccinated adults. Can Indians travel? India
Impossible Foods launches chicken-less chicken nuggets in restaurants in US
Impossible Foods launches chicken-less chicken nuggets in restaurants in US Technology
FDA adds warning of rare reaction risk to J&J vaccine
FDA adds warning of rare reaction risk to J&J vaccine World
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
COVID-19
COVID-19: India reports 3,275 new cases, 55 more deaths
COVID-19: India reports 3,275 new cases, 55 more deaths India
Punjab: 71 COVID-19 cases reported from Patiala's law university
Punjab: 71 COVID-19 cases reported from Patiala's law university India
India registered higher deaths, fewer births in 1st pandemic year
India registered higher deaths, fewer births in 1st pandemic year India
COVID-19: India reports 3,205 new cases, 31 more deaths
COVID-19: India reports 3,205 new cases, 31 more deaths India
COVID-19: India reports 2,568 new cases, 20 more deaths
COVID-19: India reports 2,568 new cases, 20 more deaths India
More News
Related
Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity'
Pfizer-BioNTech vaccine 'safe' for kids aged 5-11; generates 'robust immunity' World
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October India
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA World
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine India
Next News Article
Next News Article

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022